| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 17.34 | 8.3% |
| Total Income | 17.34 | 8.3% |
| Expenditure | 18.82 | 7.2% |
| PBT | — | |
| Net Profit | -1.61 | 5.9% |
| OPM | -8.54% | 1.35pp |
| NPM | -9.26% | 1.25pp |
| EPS | -0.04 | 0.0% |
Rockwell Medical Reports Q1 2026 Net Sales of $17.3 Million
07 May 2026 · 7 May, 3:51 pm
Summary
Rockwell Medical announced its financial results for the first quarter of 2026, reporting net sales of $17.3 million, an 8% decrease year-over-year. Gross profit remained consistent at $2.9 million, with a slight improvement in gross margin to 17%. The company's net loss increased slightly to $1.6 million, while adjusted EBITDA improved to ($0.3) million. Management is focused on growth, improved gross margin, and generating positive cash flow in 2026, with operational changes expected to generate over $3 million in additional gross profit annually.
Key Highlights
- 1
Rockwell Medical reported net sales of $17.3 million in the first quarter of 2026, a decrease of 8% compared to the same period in 2025.
- 2
Gross profit for the first quarter of 2026 was $2.9 million, consistent with the same period in 2025.
- 3
The gross margin for the first quarter of 2026 was 17%, a slight improvement from 16% in the same period in 2025.
- 4
Net loss for the first quarter of 2026 was $1.6 million, slightly higher than the $1.5 million loss in the same period in 2025.
- 5
Adjusted EBITDA for the first quarter of 2026 improved to ($0.3) million from ($0.4) million in the same period in 2025.
- 6
The company expects to generate more than $3 million in additional gross profit on an annualized basis through operational changes.
- 7
Rockwell Medical's 2026 guidance focuses on growth, improved gross margin, and generating positive cash flow.
Management Comments
Mark Strobeck
"Our financial and operational performance in the first quarter 2026 builds on the positive trajectory we have established across our key financial metrics, which we expect to continue throughout the remainder of the year." "By streamlining our operations, we are on track to generate meaningful cost savings that we believe will support sustained profitability. Our 2026 guidance is centered around strengthening revenue, expanding gross margin, and generating positive Adjusted EBITDA and cash flow."
Informational and educational content only. Not investment advice.